Logo

Course

Implementing the 72-Hour Rule in the Inpatient Setting

Details

Published Date: 04/20/2026

CE Credit: No CE

Description

In 2022, the Drug Enforcement Administration (DEA) updated its regulations to allow clinicians to administer or dispense up to 72 hours of opioids to manage acute withdrawal symptoms while arranging for ongoing care. This provision is commonly referred to as the “72-hour Rule.” Until recently, New York State regulations did not align with this federal language. Effective February 19, 2026, New York State law now permits clinicians to administer or dispense up to 72 hours of methadone or buprenorphine for the management of opioid withdrawal while arranging referral and linkage to care for individuals with opioid use disorder, consistent with federal regulations.

Presenter(s)

Zina Huxley-Reicher,MD

Zina Huxley-Reicher, MD is currently a primary care and addiction medicine provider at Health + Hospitals/Woodhull where she is the clinical lead for primary care substance use integration. Prior to this role she completed an addiction medicine fellow at Montefiore Medical Center and Internal Medicine and Primary Care residency at Yale New Haven Health. Her introduction to caring for folks who use substances came before her time in medical school at the Icahn School of Medicine at Mt. Sinai, when she worked for the New York City Department of Health and Mental Hygiene on overdose prevention and naloxone distribution projects. Over the years her work has focused on providing care to those who use substances in a large variety of settings as well as the care of those returning home from jail and prison. She is passionate about improving access to substance use care, improving policies at all levels to allow our systems to better care for those individuals and partnering with communities to include and empower patients in their own care.

Continuing Education Credit Information